| Code | 80155 | ||||||||||
| MA number | 13/0134/82-CS | ||||||||||
| Product Form: | sol inj 6x3 ml/150 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Sanofi Winthrop Industrie, France | ||||||||||
| Therapeutic Class: | 13 - ANTIARRYTHMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass ampoule | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 22.04.1982 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Cordarone 150 mg/3 ml_sol inj_06_2023.pdf
|
| PIL: |
PIL_Cordarone 150 mg/3 ml_sol inj_09_2024.pdf
|
| Safety feature | Yes |
| Data update: | 26.07.2018 |
